NCT01145352View on ClinicalTrials.gov

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

Etanercept (genetical recombination)

All patients who administrated ENBREL for active polyarticular juvenile idiopathic arthritis (restricted to the case of lack of effect by other treatment) during registered period (2.5 year).

Trial Locations (1)

Unknown

Yokohama City University School of, Tokyo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY